Author Correction: Engineered pegRNAs improve prime editing efficiency. Nat Biotechnol. 2022 Mar; 40(3):432.
View in:
PubMed
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell. 2022 01 20; 185(2):250-265.e16.
View in:
PubMed
Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nat Biotechnol. 2021 Dec 09.
View in:
PubMed
Publisher Correction: Precision genome editing using cytosine and adenine base editors in mammalian cells. Nat Protoc. 2021 Dec; 16(12):5740.
View in:
PubMed
Author Correction: Disulfide-compatible phage-assisted continuous evolution in the periplasmic space. Nat Commun. 2021 Nov 17; 12(1):6800.
View in:
PubMed
Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell. 2021 10 28; 184(22):5635-5652.e29.
View in:
PubMed
Disulfide-compatible phage-assisted continuous evolution in the periplasmic space. Nat Commun. 2021 10 13; 12(1):5959.
View in:
PubMed
Reconstruction of evolving gene variants and fitness from short sequencing reads. Nat Chem Biol. 2021 11; 17(11):1188-1198.
View in:
PubMed
Engineered pegRNAs improve prime editing efficiency. Nat Biotechnol. 2022 Mar; 40(3):402-410.
View in:
PubMed
In vivo somatic cell base editing and prime editing. Mol Ther. 2021 11 03; 29(11):3107-3124.
View in:
PubMed
Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning. Nat Biotechnol. 2021 11; 39(11):1414-1425.
View in:
PubMed
Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature. 2021 07; 595(7866):295-302.
View in:
PubMed
Phage-assisted evolution of botulinum neurotoxin proteases with reprogrammed specificity. Science. 2021 02 19; 371(6531):803-810.
View in:
PubMed
Massively parallel assessment of human variants with base editor screens. Cell. 2021 02 18; 184(4):1064-1080.e20.
View in:
PubMed
Precision genome editing using cytosine and adenine base editors in mammalian cells. Nat Protoc. 2021 02; 16(2):1089-1128.
View in:
PubMed
Laboratory evolution of a sortase enzyme that modifies amyloid-ß protein. Nat Chem Biol. 2021 03; 17(3):317-325.
View in:
PubMed
In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice. Nature. 2021 01; 589(7843):608-614.
View in:
PubMed
Integrated molecular drivers coordinate biological and clinical states in melanoma. Nat Genet. 2020 12; 52(12):1373-1383.
View in:
PubMed
Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer. Clin Cancer Res. 2021 04 01; 27(7):2011-2022.
View in:
PubMed
Phage-assisted continuous and non-continuous evolution. Nat Protoc. 2020 12; 15(12):4101-4127.
View in:
PubMed
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy. J Clin Invest. 2020 08 03; 130(8):4266-4281.
View in:
PubMed
Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade. Cancer Discov. 2020 09; 10(9):1296-1311.
View in:
PubMed
ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer. Cancer Res. 2020 06 01; 80(11):2094-2100.
View in:
PubMed
Identification of cancer driver genes based on nucleotide context. Nat Genet. 2020 02; 52(2):208-218.
View in:
PubMed
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat Med. 2019 12; 25(12):1916-1927.
View in:
PubMed
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer. Cell Rep. 2019 11 19; 29(8):2355-2370.e6.
View in:
PubMed
Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2019; 3.
View in:
PubMed
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer. Clin Cancer Res. 2019 09 15; 25(18):5561-5571.
View in:
PubMed
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal Cancer. Cancer Immunol Res. 2019 08; 7(8):1230-1236.
View in:
PubMed
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia. J Clin Oncol. 2019 06 01; 37(16):1403-1411.
View in:
PubMed
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group. Am J Hematol. 2019 05; 94(5):E146-E149.
View in:
PubMed
Mechanisms of Resistance to Immune Checkpoint Blockade. Am J Clin Dermatol. 2019 Feb; 20(1):41-54.
View in:
PubMed
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Cell. 2018 11 01; 175(4):984-997.e24.
View in:
PubMed
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer. J Clin Invest. 2018 10 01; 128(10):4441-4453.
View in:
PubMed
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors. Nat Genet. 2018 09; 50(9):1271-1281.
View in:
PubMed
ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer. Clin Cancer Res. 2019 02 01; 25(3):977-988.
View in:
PubMed
The long tail of oncogenic drivers in prostate cancer. Nat Genet. 2018 05; 50(5):645-651.
View in:
PubMed
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer. Cancer Discov. 2018 04; 8(4):417-427.
View in:
PubMed
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer. Nat Commun. 2017 12 19; 8(1):2193.
View in:
PubMed
Toward Molecularly Driven Precision Medicine in Lung Adenocarcinoma. Cancer Discov. 2017 06; 7(6):555-557.
View in:
PubMed
Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma. JAMA Oncol. 2016 Aug 01; 2(8):1094-6.
View in:
PubMed
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine. Genome Med. 2016 07 26; 8(1):79.
View in:
PubMed